Locus Biosciences
locus-bio.comLocations
Morrisville, NC, USA · United States
industry
Transportation · Health · Biotechnology · DeepTech
Size
51-200 employees
Stage
Series B
founded in
2015
Locus Biosciences is a developer of a CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease. The company's platform combines the antibacterial power of CRISPR-Cas3 with the efficient, safe delivery of bacterial viruses called bacteriophage, enabling physicians to begin treatment more quickly, resulting in a better medical outcome.
Something looks off?Open jobs at Locus Biosciences